Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period
We expect that if we address the obesity issue in this country, then in theory, it should create savings down the road for cardiovascular conditions, liver conditions and kidney conditions, he said
These people diagnosed and discovered a serious medical condition that was easily treatable and I owe them an extreme depth of gratitude. Our members love us Nicolas C
[12] [13] There is also consideration regarding pancreatitis risk
Additionally, some individuals taking these medications for diabetes or weight management have reported spontaneously reduced alcohol intake in observational studies